Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the second dose of the Pfizer vaccine, according to a study released today by the Centers for Disease Control and Prevention.

Israel initiated a national vaccination campaign using the Pfizer vaccine in December, prioritizing people over 60, health care workers and people with underlying medical conditions. By February, the ratio of COVID-19 patients aged 70 and older requiring mechanical ventilation declined 67% compared with that of patients under 50, the least vaccinated age group.

The authors said the findings provide preliminary evidence of the effectiveness of vaccines in preventing severe cases of COVID-19 in Israel.

Related News Articles

Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…